Ningjia Shen

520 total citations
17 papers, 319 citations indexed

About

Ningjia Shen is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Ningjia Shen has authored 17 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Ningjia Shen's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (4 papers) and RNA modifications and cancer (4 papers). Ningjia Shen is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (4 papers) and RNA modifications and cancer (4 papers). Ningjia Shen collaborates with scholars based in China and United States. Ningjia Shen's co-authors include Wenlong Yu, Bin Yi, Yongpeng Wei, Yongjie Zhang, Tong Kan, Yan Shi, Bin Zhu, Yongjie Zhang, Shuang Li and Xiaohui Fu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Frontiers in Immunology.

In The Last Decade

Ningjia Shen

15 papers receiving 317 citations

Peers

Ningjia Shen

SURGE

ONCOL

PRM

Dehai Wu China

Haizhou Guo China

Jin‐Ling Duan China

Jinyu Xiang China

Jinsei Miyoshi Japan

Bensong Duan China

Miho Okano Japan

Yong Du China

Liguang Yang China

Makoto Abue Japan

Dehai Wu China

Ningjia Shen

161 ×0.9

111 ×0.6

53 ×0.6

SURGE

68 ×0.9

ONCOL

44 ×0.6

PRM

Citations per year, relative to Ningjia Shen Ningjia Shen (= 1×) peers Dehai Wu

Countries citing papers authored by Ningjia Shen

Since Specialization

Citations

This map shows the geographic impact of Ningjia Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningjia Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningjia Shen more than expected).

Fields of papers citing papers by Ningjia Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningjia Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningjia Shen. The network helps show where Ningjia Shen may publish in the future.

Co-authorship network of co-authors of Ningjia Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ningjia Shen. A scholar is included among the top collaborators of Ningjia Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningjia Shen. Ningjia Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Luo, Jia‐Qi, Yijing Nie, Ningjia Shen, et al.. (2025). Porous TPU piezoelectric composites with core-shell structured PZT@CMCS particles for enhanced energy harvesting. Science China Materials. 69(1). 439–446.

Pan, Hongyu, et al.. (2024). Perioperative Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: a phase II trial. Nature Communications. 15(1). 9350–9350. 7 indexed citations

Pan, Hongyu, Cheng Yang, Jin Zhang, et al.. (2024). Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4118–4118. 1 indexed citations

Shen, Ningjia, Bin Zhu, Wei Zhang, et al.. (2022). Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients. Frontiers in Oncology. 12. 891917–891917. 7 indexed citations

Shen, Ningjia, Yan Shi, Xiaohui Fu, et al.. (2022). Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data. Frontiers in Immunology. 13. 1009789–1009789. 79 indexed citations

Yin, Lei, Jie Wang, Zhenghua Xie, et al.. (2022). Chimeric transcripts observed in non-canonical FGFR2 fusions with partner genes' breakpoint located in intergenic region in intrahepatic cholangiocarcinoma. Cancer Genetics. 266-267. 39–43. 2 indexed citations

Duan, Anqi, Bin Yi, Ningjia Shen, et al.. (2020). <p>Long Noncoding RNA <em>NEAT1</em> Upregulates Survivin and Facilitates Gallbladder Cancer Progression by Sponging microRNA-335</p>. OncoTargets and Therapy. Volume 13. 2357–2367. 13 indexed citations

Bo, Zhandong, Zhimin Geng, Zhangjun Cheng, et al.. (2020). [Clinical value of extended radical resection for pT3 stage gallbladder cancer].. PubMed. 100(39). 3086–3092. 1 indexed citations

Bo, Zhiyuan, et al.. (2019). [Applicational value of modified pancreaticojejunostomy and risk factors of pancreatic fistula following pancreaticoduodenectomy].. PubMed. 57(6). 434–439. 1 indexed citations

10.

Zhang, Yongjie, Ningjia Shen, Wenlong Yu, et al.. (2019). Tumor mutation burden in biliary tract cancers with ERBB family or DNA damage repair gene mutations.. Journal of Clinical Oncology. 37(15_suppl). e15602–e15602. 1 indexed citations

11.

Yin, Lei, et al.. (2017). Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells. Drug Design Development and Therapy. Volume 11. 2841–2850. 6 indexed citations

12.

Kuang, Jie, Qinyu Li, Fei Fan, et al.. (2017). Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma. Oncology Letters. 14(1). 41–46. 10 indexed citations

13.

Yu, Wenlong, et al.. (2014). Effect Evaluation of Vascular Resection for Patients with Hilar Cholangiocarcinoma: Original Data and Meta-analysis. Cell Biochemistry and Biophysics. 69(3). 509–516. 18 indexed citations

14.

Yu, Wenlong, et al.. (2014). Effect evaluation of vascular resection for patients with hilar cholangiocarcinoma: original data and meta-analysis.. PubMed. 61(130). 307–13. 7 indexed citations

15.

Luo, Xiangji, Tong Kan, Yongjie Zhang, et al.. (2013). TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. Molecular BioSystems. 10(3). 679–685. 47 indexed citations

16.

Wei, Yongpeng, Ningjia Shen, Guang-Shun Yang, et al.. (2013). Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling. Molecular and Cellular Biochemistry. 381(1-2). 139–144. 35 indexed citations

17.

Wei, Yongpeng, Ningjia Shen, Tong Kan, et al.. (2013). miR-204 Inhibits Epithelial to Mesenchymal Transition by Targeting Slug in Intrahepatic Cholangiocarcinoma Cells. Cellular Physiology and Biochemistry. 32(5). 1331–1341. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact